Streetbeat News

Earnings

TXT

Textron reported strong Q2 results and raised its financial outlook, leading to a rise in its share prices.

Portfolio Pulse from Bill Haddad

July 27, 2023 | 1:19 pm

FFNW

First Financial Northwest (NASDAQ:FFNW) reported Q2 earnings of $0.16 per share, missing the analyst consensus estimate of $0.20 by 20%. This is a 48.39% decrease from the same period last year. The company also reported quarterly sales of $10.31 million, missing the analyst consensus estimate of $10.90 million by 5.42%. This is a 12.81% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 1:18 pm

CCL

CUK

NCLH

Cruise stocks are trading higher following Royal Caribbean's strong Q2 results and increased guidance. This includes Carnival Corporation (CCL), Carnival PLC (CUK), and Norwegian Cruise Line Holdings (NCLH).

Portfolio Pulse from Bill Haddad

July 27, 2023 | 1:18 pm

FFNW

First Financial Northwest reported Q2 earnings of $0.16 per share, missing the analyst consensus estimate of $0.20 by 20 percent. This represents a 48.39 percent decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 1:18 pm

RCL

Royal Caribbean reported strong Q2 results and increased its guidance, leading to a rise in its share prices.

Portfolio Pulse from Bill Haddad

July 27, 2023 | 1:16 pm

BMY

Bristol-Myers Squibb reported worse-than-expected Q2 results and lowered its FY23 guidance, leading to a drop in its share price.

Portfolio Pulse from Bill Haddad

July 27, 2023 | 1:13 pm

CROX

Crocs Inc reported Q2 FY23 sales growth of 11.2% YoY to $1.07 billion, beating the analyst consensus. The company raised its FY23 sales forecast and adjusted EPS outlook. Despite the positive report, CROX shares are trading lower by 5.06% in premarket.

Portfolio Pulse from Shivani Kumaresan

July 27, 2023 | 1:13 pm

SPGI

S&P Global's shares are trading lower after the company reported mixed Q2 results.

Portfolio Pulse from Bill Haddad

July 27, 2023 | 1:09 pm

LOVFF

Cannara Biotech Inc. reported its Q3 FY23 financial results, showing a 57% YoY increase in net revenue to CA$15.9 million ($12 million). Other highlights include an 81% increase in gross profit to CA$8.6 million, a 105% increase in adjusted EBITDA to CA$3.9 million, and a 107% improvement in net income to CA$2.9 million. The company also reported a 113% increase in free cash flow to CA$3.2 million and has CA$27.1 million in working capital. Cannara's market share grew by more than 30% in Quebec and Ontario, and it began sales in Alberta.

Portfolio Pulse from Vuk Zdinjak

July 27, 2023 | 1:09 pm

AMAT

ASML

KLAC

LRCX

MPWR

MU

MX

NXPI

ON

SLAB

Semiconductor and chip stocks are trading higher following strong Q4 results from Lam Research.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 1:08 pm